0001144204-11-047860.txt : 20110816 0001144204-11-047860.hdr.sgml : 20110816 20110816135038 ACCESSION NUMBER: 0001144204-11-047860 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20110816 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20110816 DATE AS OF CHANGE: 20110816 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HealthWarehouse.com, Inc. CENTRAL INDEX KEY: 0000754813 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] IRS NUMBER: 222413505 STATE OF INCORPORATION: DE FISCAL YEAR END: 1202 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-13117 FILM NUMBER: 111039528 BUSINESS ADDRESS: STREET 1: 100 COMMERCE BOULEVARD CITY: CINCINNATI, STATE: OH ZIP: 45140 BUSINESS PHONE: (513) 618-0911 MAIL ADDRESS: STREET 1: 100 COMMERCE BOULEVARD CITY: CINCINNATI, STATE: OH ZIP: 45140 FORMER COMPANY: FORMER CONFORMED NAME: HealthWarehouse, Inc. DATE OF NAME CHANGE: 20090818 FORMER COMPANY: FORMER CONFORMED NAME: CLACENDIX, INC. DATE OF NAME CHANGE: 20080107 FORMER COMPANY: FORMER CONFORMED NAME: ION NETWORKS INC DATE OF NAME CHANGE: 19990413 8-K 1 v232442_8k.htm FORM 8-K
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.  20549
FORM 8-K
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 16, 2011
 
HealthWarehouse.com, Inc.
(Exact Name of Registrant as Specified in Charter)
 
Delaware
  
0-13117
  
22-2413505
(State or other jurisdiction
  
(Commission File Number)
  
(IRS Employer
of incorporation)
  
 
  
Identification No.)
         
7107 Industrial Rd.
    
Florence, KY
  
41042
(Address of principal executive offices)
  
(Zip Code)

Registrant’s telephone number, including area code:  (513) 618-0911
 
 (Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 DFR 240.14a-12)
 
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
¨
Pre-commencement communications pursuant to Rule 13e-4 (c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 
 
Item 2.02
Results of Operations and Financial Condition.

On August 16, 2011, HealthWarehouse.com, Inc. issued a press release to report its financial results for the quarter ended June 30, 2011.  A copy of the press release is attached hereto as Exhibit 99.1.

Item 9.01
Financial Statements and Exhibits.

(d)
Exhibits

 
99.1
Press Release dated August 16, 2011.

This information, including the press release filed as Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933.

 
 
 
 
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date:  August 16, 2011
  
HEALTHWAREHOUSE.COM, INC.
     
 
By:
/s/ Lalit Dhadphale
  
   
Lalit Dhadphale
   
President and Chief Executive Officer

 
 
 
EX-99.1 2 v232442_ex99-1.htm EXHIBIT 99.1

EXHIBIT 99.1
 
HealthWarehouse.com Reports 43% Revenue Growth Year-Over-Year
 
Prescriptions Filled Increase 147% Year-Over-Year
 
CINCINNATI, August 16, 2011 -- HealthWarehouse.com, Inc. (OTC: HEWA) a leading VIPPS accredited retail mail-order pharmacy, today announced its financial results for the quarter ended June 30, 2011.
 
For the quarter ended June 30, 2011, the Company’s net sales increased $753,059 to $2,519,721, up 43% compared to the same period in 2010. This was driven by growth in the Company’s prescription business.  Prescriptions filled increased from 15,191 to 37,458, up 147% year-over-year.  Gross margins increased from 27.4% to 44.3% year-over-year due to prescription orders becoming a larger part of the product mix.
 
Selling, general and administrative expenses increased by $1,062,069 for the quarter ended June 30, 2011 compared to the same period in 2010.  Net loss for the quarter ended June 30, 2011 increased to $1,100,094, as compared with a net loss of $649,329 for the same period in 2010. The increase in SG&A expenses and net loss was due primarily to the expansion of personnel to handle growth in prescription sales as well as non-cash and one time charges.
 
“We are pleased to report strong revenue and gross margin growth again in the quarter,” said Lalit Dhadphale, President and CEO of HealthWarehouse.com. “With prescription growth of 147% year-over-year, it is clear that customers are looking for an alternative to expensive, brick-and-mortar pharmacies.  We look forward to further broadening our customer base and continuing our growth.”
 
Forward-Looking Statements
 
This announcement contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Actual results may differ significantly from management's expectations. These forward-looking statements involve risks and uncertainties that include, among others, risks related to competition, management of growth, new products, services and technologies, potential fluctuations in operating results, international expansion, outcomes of legal proceedings and claims, fulfillment center optimization, seasonality, commercial agreements, acquisitions and strategic transactions, foreign exchange rates, system interruption, inventory, government regulation and taxation, payments and fraud. More information about factors that potentially could affect HealthWarehouse.com's financial results is included in HealthWarehouse.com's filings with the Securities and Exchange Commission, including its most recent Annual Report on Form 10-K and subsequent filings.
 
7107 Industrial Blvd. • Florence, KY 41042
Tel: (866) 885-0508 • Fax: (866) 821-3784 • www.HealthWarehouse.com

 
 
 
 
 
SOURCE: HealthWarehouse.com, Inc.
 
About HealthWarehouse.com, Inc.
 
HealthWarehouse.com, Inc. (OTC: HEWA) is a trusted VIPPS accredited retail mail-order pharmacy based in Cincinnati. HealthWarehouse.com offers 300 prescription drugs for $3.50 with 100% FREE shipping and is a 2009 & 2010 winner of the BizRate Circle of Excellence Award for outstanding customer satisfaction and service. With a mission to provide affordable healthcare to every American by eliminating inefficiencies in the drug distribution chain, HealthWarehouse.com has become one of the fastest growing retail mail-order pharmacies in the United States. HealthWarehouse.com is licensed in 50 states and only sells drugs which are FDA-approved and legal for sale in the United States.
 
Visit HealthWarehouse.com online at http://www.HealthWarehouse.com.
 
7107 Industrial Blvd. • Florence, KY 41042
Tel: (866) 885-0508 • Fax: (866) 821-3784 • www.HealthWarehouse.com

 
 
 
 
 GRAPHIC 3 logo.jpg GRAPHIC begin 644 logo.jpg M_]C_X``02D9)1@`!`0$`8`!@``#_X0!F17AI9@``24DJ``@````$`!H!!0`! M````/@```!L!!0`!````1@```"@!`P`!`````@```#$!`@`0````3@`````` M``!@`````0```&`````!````4&%I;G0N3D54('8U+C`P`/_;`$,``0$!`0$! M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$! M`0$!`0$!`0$!`0$!`?_;`$,!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$! M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`?_``!$(`"T! M;@,!(@`"$0$#$0'_Q``?```!!0$!`0$!`0```````````0(#!`4&!P@)"@O_ MQ`"U$``"`0,#`@0#!04$!````7T!`@,`!!$%$B$Q008346$'(G$4,H&1H0@C M0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U-CH.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJ MLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X M^?K_Q``?`0`#`0$!`0$!`0$!`````````0(#!`4&!P@)"@O_Q`"U$0`"`0($ M!`,$!P4$!``!`G<``0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B M7J"@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>X MN;K"P\3%QL?(RKR\_3U]O?X^?K_V@`,`P$` M`A$#$0`_`/[^*_.7_@H=^WYH_P"P)X1\!>+M:^&^H_$F'X@>)M0\-VUCI?B" MT\/2Z9)IVDMJ;W<\]YIFJ1W*2A5A6)(H7C8F1I&4!#^@\.I6=X)#:WEM.(9I M8)3;S13B.:WE>WN(9#$[;)(+B*2"9&(:*9&CD"NI4?SD_P#!QVRGX)?LZ,.? M^+I^)V9@>`/^$1QD,!@+QMSZ@CKFO.S3$UL-E^)Q6%DO:T8#/&D7@Z73-3U^VU^:_G M;0M-UHWT=Q:Z=IT<$0AU&&#R6CD&[/4(M*N=2_M[Q3HGA:-8=0GMKR&V-M+K:7C-):S!X[=X@F MYU9?QM_X-R'V?LU?'8'`_P"+XP@@]0?^$`\*8X'K[_SK[M_X+(.#_P`$X/VD M<'_EP^'1'(/3XN>`0<#&3@^OY#I6.$Q>)GDL<;5DUB7A*U7FTTJ151QT5U96 M2MY6OU/G^'N+,[S+P:CQAB,0Y9W/A;-,S^MN@J6_\$^O^"L/AS]O'XN^)_A5HWP;UKX=7'AKX>WOQ#?5]4\6:=K\%[#8 M>)/#'AU],6SL]%TR2":4^*([I+HW$J(MFT;12,P+QE5.5ZOM*LN M6$(J,DHJRMJUK>SOK=F?@SQIF7%7AW0XFXHQN%^M1QF9T\9C)*E@\-3H8?$2 MG"I.Y[#17Y#Z-_P6]_X)[ZSXC'A_\`X6QX@T>,SF(> M(-;^'WBJV\-MEQ$DC7\5C-<6T#N0?/O+.&.-0SS&)%D9/U)\'>-_"GCWPYI7 MB_P;XCT?Q3X7URVBO=&U[0M2M-3TK4[2=%>*>UO+1Y895;<5(#;XW#(X#KBO M5H8K#8I7PU>C72W=.K"3OIIRJ7,_DK:;GZ+DW%'#G$4JL,BSW*LWJ4%%UJ>7 MXVABZE)3DXP+M"BDF,::KK7PW\50Z."'2+#3V-CJ-X%!82%_L>WRV M5R5!R(GC<'3G[.IBL/"6O-&=:G&47I92C*2DF[Z*UWIW.+'<=<&99C7EN8\4 MY%@L>I34H+&?PW=S6R73V1= M()+J5H8Y"7DE8;*_>'XF>.OAGXRT'QSX/UJ`SZ5XA\-:A;:EI MMV@SN"SP$^7/&05FMY0DT+#9+&C9K_/0_P""@)S^W'^UB0,#_AH'XHX'H#XR MUPX'TKR\]S'$8##8;$8.K%*KB(4I2BU)2A.VW3Y^NC3/R?QZ\0,]X-X=X>S3 MA7'8:']J9I/#5:RA2Q='$8.KA)VG2FFZ;7,WRRC)WZI*S/\`0P^&_C&#QQ\/ M_!7CB&T?3X/&7A3P[XKBT^>1)7L(O$.D6>K16E6- MQ/=626D(WR->)`%X!Y90?R=_:<_;=_9O^$O[$C?L_>,/B"+#P?XXTV]UR:PU?5(H;[6-,6"QB:RT/3]4 MU$FYN<`S16;I%ES*Z>9\RQ.=4\+BL+AE.C5=2:C6J3GRN@]')3;M%.Z:;NNW MKU\2>,^!X>S_`(*X;A_9>82SR>$I9[F%7,J.'ADU/FP]'$QQ5"#G&&(DZC48 M5YTH1WDTXV?]@?\`P4%_;BTC]@KX8>$/BGK'P^O_`(C6WBOX@VG@)-)TK7[? MP]<6DMYX;\2^(5U![NZT[4HYH8D\/O;&`1+(TET9%E1$9'RO^">_[>VC?M_> M"O'OC71OAQJGPWM_`GBFS\+7&G:KXAM?$4FH2W>D0:LE[#%-#_:PL/!^I:K'HVO MZ(+;Q'8_"'QMK%UIIM?$6F:9>2&/3=>TRY:>.$V[&<11322I.D=/_@AC\=OA M-^SM^R?^TC\1OC)XYT7P'X2LOC%H-L^I:Q+(6N[N7P79M!I^F:?;)-J&K:C< M!)##8Z=;7%TRQR.(RB,1#S>;SQ82-2DL#]7C)5'*+YIWG=J47)6V>_5:6L>; M_P`1-S"7C3#AZ.>Y<^"UPLL\G.+H+#RG1P-*M/%4&A4E=QIRDKW:N M^>,?ZGNE?(G[5'[3]M^S3;>$[Z^\%7WBNS\57>HVBS6>LPZ4+*?38;6=HYDE ML;OSEN(KH>65*$&*3.,;C\P_#?\`X+-?L$?$_P`8V?@O2OBW?>'=1U"^CTW3 M[[QMX4UWPSH-]>S,$@@CUJ\MCI]EY[8\J359[&%V=$\P221+)Z)_P4D\+#Q/ M^SJ?$5N!/_PB'BK0=<$J;&"6>I&XT"1U=0V^)GUBT8J&V/A&.3MQX/B+FV98 M3@7B3-.%L?2IYMEV!>*PM:$(XCD="K1JUKTWVH1J-MK1)Z=3]MR_B/)\[PN+ MQ'#^;Y?FCPC]G4G@L33Q-.E6WY*DJ;DD[)VM>[M8^E/V<%TE2 MW\/AY48\)>6C`8=#7Y;CO%3.(^!67<SNVW)-VZ=OUN53+UB&TJKBE9V4554N5VZ-.SZ:)I]+K["_9] M_;U\._'CXDV/PYB\`ZIX6O-2L-1OK/4+O7[34H)I--@%S):BVBT^T=7DA69_ M,20D>3RI!./O#7=2M-%TK4=7O'6.TTZPO+^Y=VVHD%I"US,790S`".-R2%8! M5QU.;RI=*\6^'K.]D=&7_B7^,])M[>6)E<)@BP M\0M&-ZY$T<>#OP:_=#]KCQ4/!W[.'Q;UM)5BE/A:ZT6T<#E;KQ+-;>'K4Y&& MQYVJ*S$9Q'N8D@''3X4>(^>YWP'QCF?%>*H5,ZX3GFGUET\-'".C2H8"IC,' M"=.,G>HI0G";DHKGBXQJ2T;]ZUOT/`/@ M1^WYIOQQ^)V@_#72?ACK&COK,>J7,FLW7B.RO8-/L]+TV[OVGFM(M,AEE$KV M\%DH2==DMY"Y9E4@_HDN""1Z]3U/^XGNYBL$"06.DW*R&1U0)-N/.UA^A_B/]OK]F3PQ= MS63^/I=?FBD\N1_#.A:IJEHDF2I1;X01V$RC;GSH+J6(E@`[,"J]?A1XEU,= MP-0XD\0>(LHP=;,LSS*.75<94PN4QJY;@JD**JTJ52I%UHPK.<%4LIS5GRW= MAX/$.6'57$U*<93G+EU2NKI)--+5ZNZT/M2BOECX:?MB_`'XJZO:Z%X9\>0P MZY>_+8Z+KUE=Z'>7TA(`2R:_B2UO)&.52"VNY9GVN5B8([#V'XB_$_P;\*O# M4_C'QUK1T7P[;75E:S7_`-CO+X1SW\OD6L;0Z=;75P1+)\I98BB$,6..!^P8 M3BCA[,,OJ9K@,XR_&Y90BYXG'8;%4JN'P\+74ZTXR?+%O3FLTMW979VQG3G% MRA.$HJ_,XM/EM_-V]7H]UH>C45\]>&?VHO@?XN\)>*?'&B^/-/D\+>#7MHO$ M6KWUKJ6E06$MZKO:1;=3L;2>YEN0A2"*TBGD>4K&HW,H-WX,?M"_#OX[IXBN M/A[J5_J5IX9O+:RU*:_TJZTQ6FO4EEM6MA=QQ22121QM\YB7YEVX#!JG#<5\ M.8O$9?A<-G.7U\1FU"KBLMI4<33J3QN&H-1JUZ,8.3]G"5XN4N76+ML+VE-R M454@Y2ORQ4KRE;>RZVOJ>\45\Q_%C]K;X'_![4I-#\6>-(#X@C5#+H6B6=WK MFI6OF%=@OEL(Y8+&1E.Y+>[FCG=")$0J1EOPK_:X^!GQ@U�_"7C>(Z_=!O MLVA:Q8W>AZE=!59BUG%J$0AOFVY;R;2ZEFPF6B0%=W++C?A%9I+)/]9,E_M: M,DI9>LRP2LVE[:CS]S:*UNZO MTN=/^T'\9[3X"?#C4?B->:#<>(K:PU'2M/;2[2]BT^:5]5N_LRS"YFMKN-5B MW>8R^5ER6&[D$>4?LO\`[6>E?M.7_C&RT_P7J'A1_!]GHUR\E]K-OJ@NQK4N MHP1I$L%C9^48/[-D9R^_?YB!1P2.6_X**MG]F+Q)VQXG\)`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`773],LTGO[ME+ M*',%O(L8;?(R*"U?.&G_`/!0W]F6^NULY/%^LZ86?8MWJ?A36X[-@7*"0&W@ MN90O3!=%./F*KV\G-.-^$H0ZEH^ MMZ?::KI6HVQ)@OM.O8$N;2[@WJC^5<02QRQEADHP)X-?/OQ1_:]^!'PBU2;0 M?%GC6&37[;B[T70K.ZUS4+)BJNJWT=A#)!8S,KJPM[RYAE9&5E5@W'I9EQ!D M>3X.EF&:9ME^7X"LH.CC,7BJ5##U542=/V52I*,:GM$TX\C>FKLFF.52$(J5 M22A%ZWEHK=[[?J?3U%?-/PK_`&LO@;\8=3CT/P;XWA?7YD>2#0=8L[G1=4NE MC5FE^Q07\$27IB5&DECLY[B6)`6=%0$CZ45@>X/'8YY[_EZUKE>=93G>&6,R M?,L%FF%G<_DP_X*CZ M=^W)^Q/^T?XZ_:$_9U^(/Q,\-?`SXS3Z;XJUJ[\,,NK^$/"WC:/2=/T77;?Q M)HFH:?JFC:7/JDFCV^LVVJW>FO;7[7\MJ;J.XBDA;\0_C[^VE^T]^U%H^@>' MOCY\5]2^(ND^%]3N-7T*SU#0O"FFQV&HW5N]G<7<;>'/#^B37$MQ:,(&2[>X MB10/)C0X:O\`2`ELXKF-H;B&&:*12LD%M9UKXG^(X=7U?PYX9T71M3U:*/PKYD<.IWV MG65O=7R))B11$F[4[W223;33UORK M[NW\B^-?A;FN`R7BKBK+.-,VP^26J9GCN&,75Q>*PT!M!\,Z M[IFJZLMK!8B6\37=&U*ZB=[:VB@E-E=V[B,!0R_+C]3O&_\`P5NU;]KO]@W] MIGX#_'#0=%T3XOQ^&/!.M^%?$GAJ&6PT/QQIVD_%+X=7>I6EYI5U=7,FE^(K M*RG_`+0;[*XTO4;*"XDLX;22".*\^Q_^#?OX7?#?XB_LU?&]O'GP^\%>-VMO MC9##`WBSPOH?B%X(?^$$\,3+%`VKV-V8HUFFGF5(RH$LLD@`=V8][_P6&_X) MW?LO^'/V4_B7^T3\//AGH7PP^)/P\N_"FHQ7G@6SAT/2?$EKKWC+0O#%Y8:_ MH-HT>CS!4UUK^._M[*'4XY[5$^U2P.UN>7`X#,J65O%TL="IAJF%K.IA*T)- MQ@U)2=*;E:_+>2:25]'?4^4X9X+\1,N\+Y\3Y-QA3Q>08_AC,ZF.X6S.-6M1 MI9;4HXFA6^HUYRE&CB:5.G/$4_8NDKS2J*4KN7YW_P#!NN1_PV#\63D@#]FG MQ(O/#`#XE_"H*3C."5`8XSC/M7AW[9OQ2\=_\%)_^"BVE?!G0-=GM?`]M\3! M\%?A?;-YTFE:1HNGZP^G^(_&TE@A\J:^U6:SU+Q#-=D"5M*M=-M6EBM[3`]I M_P"#>3S6_:W^,@M]OGM^S#XH:W\W)3S#\1OA6T:R%/F*J[!6*@,RKD`$U^3? M[-?@[XV>._VDO`G@WX,^))O!GQSU[Q3J=AX7\2WFN7/AJ[TSQ/'I>JR:A)<: MY;0RS:?=2P)J5E(R6TTLEU*+6.,F>5T\VE7E#)+M'^+?PX\#:G MXMTWQ9J'B2_U9/&-[X?\`!OE^TMXBTGXJ>.OV6-XN7DFB:**)YF).XMZ_L:\):M7+\-A,)BLND MI1E4Q,\#5=-^RHQY^>M2YI>[*I)2NW][_M!_\$>/AK^U?^UIXS_:&^,/COQ! M:>#]:T?PII^E>`O!'V;2]4U"ZT'0[73+R\\0^(KVUO72W>:)DMK32K)+IHTA MEGU.$`V=?'O[?G_!%/\`9I\`_LV_$7XM?L__`/"6>$?''PK\,7?B^XTK5O$] MUXBT+Q?H^A12W6MZ;?PZI#++I^I/IINKO3[O3[FU@:_M[>&\@>"9VC^%OB=_ MP4/_`&XO^"A_[2=I\"?V7/%^O_##P;XI\0:AI7@?PUX8U1O"MY=Z!8B\N9_% M?Q#\8V*SZW$D>DV\FI:I9Z==KIEBCK;6]E?WT:2S?1?QE_X(X?'7X;_L_P#Q M5^+/Q:_;@\5^)M1\$_#GQ+XKU?PS;)XOU?0]732=&FNY-#N=8\2>,(9Y;:\D M@-I/>3Z(@EA;+V((*559X#&0Q]3!Y/+%TYSKRGCJDXPAS16LJ5:LL M-)0K>QPL81<$E&#YU?F_^#=;XQ>)+'XO?&CX$3ZC/-X0UWP$/B5IFG2S-):V M/B;P]KF@^'=0NK*!MLBW&L:/KR->3%F\U-'LDE9W13#^/O\`P4!&/VX_VL!G M./V@?B@,^N/&6N#/XU^C?_!OAD_MK>+Q_P!4%\7$`@!E8^+?!`QD%A\H!7"L MWSK(1RQ)_.;_`(*!?\GR?M98X'_#07Q1XZ?\SEKG:O(J5)U.&\`YRKU[GXUQ#B,17\!N!H5ZDZBP?&.;8+#QD_X-"C.M[.C'^[!25KWL MFE<_I._;`_X)P?`SXV?LI6?[6_BO6?'UK\2?A_\`L8^"9-(T[2-6TBW\+7!\ M#?#9=3T<7UA<:%=7\JO<7=%^T1M:L9 M%51D8Y_L5^+W_**WQ?[?L6Q_C_Q::TZ5_+O_`,$*>/\`@H/X*_[)_P#$[]?# M4KN:ZKEE*[6R^1^I>)?"W#S\3O!ZG_ M`&/@?9\0UL!5SN*HQ2S.J\1EM-RQ2_Y>.<:U12V4W*\DW9GW!_P5E_8R^%W[ M#_\`P3^^'7PN^$VI^+=4\/\`B+]L*T\=WUQXQU&QU/4UUG4/@MXJ\/3Q0SZ= MIFD6ZV(L?#%@\PFL+%M-AU2UU#2+.XAT?1Y7U#5+W3KV5;: M.UM+:`^=-+#^U_\`P<7D?\,D?!L<_P#)QFC'/;'_``K/XF=_6N+_`.#<2&+_ M`(47^T1.(H_./Q:T"-I2H\QHH_!MNT<9<#<51Y9"BDX0RR%<%VRIX&A4XAH8 M2=.,,/'#4_W,5[.[C#FG>4'&3M*=G=Z*RV22US7@SA[,_I$8#A6IE].GP_A> M&#?%NM^,_`?Q!\(7/B#P_>>*X]+;Q%INH:1J;Z;K6DZC-H]CINF7=O M"9M.OK&YM+&Q$PO+BTEM_+MG^T?TL_L%^+]<_:9_X)-Z'8^(KRZUKQ%IG@'Q MS\/WOKEVFO[^;P%JFH0^&]TC9DGO(-.T_1+7[3(9)[B>V:XF=YI9"?SD_P"# MD157Q'^RX0`"VC_$LL0,$D7OA;KP,X]R>2<5^B7_``0G02?\$^?"4;`,K>/_ M`(FQE3W#>(Y@YYZG:W<@GIG'(Q_LRC7S#/,G453PF,RG&8>I2;ER'F49?POX^\:\,9)2>!R:KD;KPRZC*:P=%SHY+B7-4Y M2:Y^>K5E&I*\XQE.,6H-H\D_X)D>)SI'QXU?P_,Y2W\6^!M1M5C#`)+?Z1=V M.JP2$'`8K9QZC$N/O>?N..`.;_:+9OC#^W1>>&(W%Q:S^//"7@%,;ABWTYM. ML=;B4KG`BN4U0$CK,AZ$G'$?"::'X&?MEZ38W4BV6G^$?B?KOA2[:1REO%I% M[+J^B$OYA!D@33KJVE1F.`ZQ29#!2.__`&-K>?XJ_MEVGC&ZCDG%OJOCCXA7 MAE"R$O.-4CLVE/0&/4=6T^Y1OOM<6^6)=CN_A_(\3+,^%>#/"J3D\30\6*^# MQU!N7M/JV#^I*7M()>TA3E/$XZ6EE?#UO^?3M_2E&SI4<%RMU(XJ,)K9JTUS MN23?+9W=]-N[-3_@HMH$W@_]I73?$6G*UL/$'A/PQXAM9XQL2#4](O;_`$9C M%@`"2"/1+29N1N^UP+E<`U]>_P#!0;XC0:G^R_\`#Y[.0;?BAK/AC5DBC=27 MTZ'0KCQ#.7Y_>1)<'3[8D9Q/-`<$[17#_P#!53PH[Z=\)O&BPAS!?:[X8NI\ M`*!J643GNTIM=0D0-E1Y3$\BOA?XY?%4^-O@Y^S'X26Z6>?P;X&UV&_B M4DO'+'XFN_#NE`\XYTSPU:[0QWF7<3R03]=QKF\>"<_\>&J9C!IMU:5'V<5?WIWC%J* M6CDXRO;JK=+L^\_V'/@[/XQ_9+^,&F^=:VE_\7-1UWPY:7UW&\EG%8V&C6VF MVEU+"J%Y(H]3N]5:2-`XD15'.XJ/4_!G_!-/X&:)HZ1^+K_Q5XQUEXC]IO\` M^TSHEC'*ZJ9?L5EIJ&6.'<&9&O+V^G))+R`X1.)UOXQ7_P"R!^QS\&-.T&SM M7\>^-=!@GTP:B@DLM.FU2$>(=9U6\A1HY+J33DU.UL;2W8"&:5[99BUO!*9/ MG+X/?"G]JG]K^RN_'NO?&76O#_A)M1N].BO=1U/5D%[=0!#>P:3X9T*?3=-^ MR64LAMI)7DM+=9XYHD%VT+$?68>KP;EV$X&X*J<`U/$#C?+>#<'5>!E&$<)E MV&S.A',L2JU?$QJX+"U)8FM0(K):T^; MV:IQ:3;E)M)66R:;DO,\+_:]_9_T_P#9N^)NDZ=X6U34Y_#GB'28O$GAZZU" M;=J^D7%M=W-M=6A>-=9D$^K:II'P_FU*7C][J]IXCL-(U"?(9N7NH+J0J68@R,I)8'/YX_M=? M`/4/@'XC\'Z)JGC_`%#X@W6N:!=ZB+S4K:XMGTV.VOVM!:P+Y[]Z^%X9C5R[B+QTR..4S MX9R^KP3FV-_U>^MPQN'RF=*G@%""K0_'6NX_& M/B2YNQ*VF6(T^,:7!J%S!!B2_O`E])9Z78EXDDGNI"]Q:QB2X3]/-8^'Z?\` M!/W]G_XHZQX<\:W'BCQ+X[O-!T?P]=76D0::=-UF6&\MOM4,<5_=)=?9;&2_ MU",OY06>S@WPF-W"^._\$J41O&/Q<8HI=?#OA@!B!N56U'5W_P#!4M9V^$'@%HE$3A$)4.?#7B'RV?`P!P5W$8W$+NY`/L>'_# MF59!X+9KXG4J=3$\6TLISFGEN,J5<1&>58:-18.5'#895%A(QC*+J2U_E9GR5^Q!^R]X>_:*O/&GQ` M^*=QK&J:%HVJ)8+:QZA<6T^O>(K^W_M#4+G4]4AVWLR6<5Q;F01W"3337`,K MF#;$>>_;<_9TT+]G'QKX,\0_#>ZU/3M`\2QW5WID4U_<3W^A>(?#\]M)*UAJ M+.+XP[+VRO;:2>>6YM[H,$F\J.%4P?V9_A/^U/X]\':UJ'P+\&?"]KXEG MM-3L(?&=WX?6;7?[,TR6>]-E;I*DC2V$FGP"[PC-Y#1>6YB+CU[QC^Q-^VQ\ M1(M/B\<^+=)\5Q:4UR^FQZ]X^NM16Q>[6%;IK9;FR?R6G6W@68I@N(HPV=HK MY'!Y+7S?PNR_`91X6<3U^*,1&EG&%XXH4*%:6*Q_]J2GBYK$4:TLPJ8:IAH^ MSIQY7_$IN<(WE(RA%U,/#V6&J.KRP?M;2=Y)Q?-?FLV[=;IVV/:?CI\4+KXP M_P#!._2/&VJ2++KEQJWA73->E0!?.UK1M=.F:A<;4&U#>/;B^,>`(Q\676G!))YY89I[;0[6T@G26Q; M47FGOF@N+Z&XAM+1;^6."28QJ?L7XG_!_P`9_!'_`()_Z_X'\=#3QK+_`(4Y/QCAL1*KB^",L_M?!XGVE.O.MA\O MSZICZ&)C&4*E.K7:Y9M.-2*@XPY;&TX.OB\##$)N+(]3MLZ\ED=3LM6T@6+O&.M/)>O\)+[Q1H&E+*P M9IXK;3]'U;0;($ME8_M/B&D4HB1QK;PJJ+'&.8_X*J@#P?\("H`!\1^)^ M@QDG3=/8D]\DL2?]HL>_/SK\+%N'_P""<7[1*VP8NOQ+T*20("6\B/5OA8]Q MPHSA80SNW01AB3@'&WU3"^'GC5QO@N$L,LMP,?#_`#G'4L%ADU2IXBCD\\?& MM[_/*52->C2JWE*3Y5:W*VG7+#"XVI"C^[A+"U79N33DHJ44N9NSYDK)271+ M30\"^!_P_P#$'[67Q_33?%>MWLG]OR:OXD\:^(%.^^CTFS$LCQ6!*&.`33R6 M>G6$+(+>VMY`RQ<8?[C_`&KOV"_AYX`^$6K^/OA;)KUIJ7@VWMM0UG2M1OSJ M<6LZ5#/%#>W4;RQ+):ZA8QR-J!$++;SPVTD0B5RA/D__``2\DMX_C?XP23:9 MYOAO?"V!QEG3Q#X=>8+N`/F)#&0XX(4J#PU?KQ^TC+;1?`+XP2W31K`OP]\3 MY:3!C!.E3B,\@Y)9:XRK^UCJ!9 ME4+\?I`S,0%4K\1XP=Q)X_'\<5^4XK-<;G'ACX:4"I4,MG/3[,:<*DI,:NV]8P<4FDTKI)VLDUM?L M?TN>.USX)\7@_P#0L:YV]=*NF'Y$=_L5 M9_X:B^$&!R=S]RS:OLG?O=_>'[3 M?B;5?B'^TWXX@\9ZM-9:=IOQ!O/!5I/,K/;^'_#&DZ^-(+V]M+_JU@T^-M5F M,(5+J9_.E,H"LOZ>6_\`P38_9\UOPS8MH7BCQJ)+RTBGMO$UGK.D7T%^LT.Z M*]2T?2)M.FAD++(JP"*9HB%%RI(83_M:_L'VOQAU:^^(_P`-KVST+Q]=0A]7 MT?46:+0?$LUO'L6\$\4=PVF:Q-#B%YC%):7C10"X-LZB\'YX?#7X]_'_`/8Y M\62>"O$^G:E_8EK.:PNI]+GG!^ MT03,':OBJV1Y9X?\9\25_%CA&/$V1\4YO5KX'B^-*=>&!I5:\G1IR:Y8T>6E M.%*M&E*G*#I-PL]^>HHX.M4^O4I5:5>2<,0KV@Y-74DM$KV[.RNMKK]7OVDO M&\O[+7[+UKIWAC46_MW3M#\/_#;P;>O!#$_VV/34LWU9K8%HXI+/2=/OKV&) M"Z+>&!&#QG(_.S]A[]E7PS^T$_C'XA_%2?4]8T'3-5&E6MC#?SV\NN^(;B$Z MGJU[JM_'B]<6L6I6,FV"YB>ZGO-\K&*")']7_;V^)NB?&7]G/X)_$+PA+/)H M&M^,;UI8+D1K^1RC.ACB,J.4<9^:?V:/A+^U9 MX]\#ZGJGP,\#Z_#I.ASW-RUC;Q.DK/87&G6IN MRC"@N2,&VIZ1M;75VWO=O=Z M*Q<_;2_9]TG]F?Q_X0USX;7VJZ;X?\10SZIHRM>2S:AX>U[0;F`7"V=^ZF.[UHVU;4M(%GKIC4(IUS M29YM,U5U0,P1+B\M9KJ./.8TG5,MMW-^3'C#]B3]MCXB"P7QSXJTOQ9'I;7+ MZ8-:\?W.H_8I+M(DNV@%U9$0^>L$"D)N):%7RIP:_33]C;X2>-?@G\&+/P)X M\CTR/6K3Q!KFH!=*OFU"U-IJ4\5Q"?/,:`2&3SC(@'#'<1ELG[+P>RKB#*?$ MOB;$X7@G.>#N"\\P-2O0R[&T(PPF$Q]%X.5J7L:<*-&=:I]:E&DGRJ-1QA'E MA%+3!4YPKU6Z,Z%.JE-4Y)I1D];6=[67V4]-/0^K:_FX_P"#D%E_X4I^SD,C M(^*GB?(R,C_BD">?P4GZ`GH*_I'KQ[XH?!7X2_&J*QTGXM_#KPA\1M-TF[EO M=*L?&.A:=KUMIMY/:F"6ZL8K^"9;:>2`&%Y8\.T;,A.#7]0YE@I9A@<3A8S4 M)5*>DFKI-2CNO^&]3P?$+ARIQ=PAG7#%'&4H^.,`(]#_PK_P`*'!]\$'\17W7_`,%D MO^4;_P"T?[V7PY`]R?BWX#`'U)X'O7W1\*O@W\*?@QI6I:)\)_AYX0^'6DZM M?KJFJ:=X.T*QT&RO]2$"6HOKJWL8HTFN1;0PP>=)N?RHD3.%KHO'_@?P?\1_ M"FJ>"_'OAK1?&'A/6A:QZOX<\1:?!JFC:FEI=P7]JE]87*O#<)!>VMM=Q*X^ M2>"*0$%!66'P,Z65QP$I)S6&J4.9;7DI)/?^\KZ_,\C)N"J^5^%\>!:F88>K MB*?#^/R9YC"E5CA^?%0Q,(UU1E^]Y(*LG*/Q/E:6Z/X^O^#=8A?VPOBJ20H; M]F?Q%M+<`X^)/PGSC/!QWQFO(/\`@I!^RK\6_P!@C]L1OVBOA?IEW:_#S7OB M-!\4_AAXRM+.2[TKPQXLEU>3Q#<>#-=&V*"VNK/6WO6TVS:XB.K>'9K=;>>2 MYAU#[/\`V*?#7]F?]G_X-:S=^)/A/\'OAW\.M?O]/DT:_P!8\(>%-(T34;S2 M)KNUOY-,N+NQMH9I+%[NQLKAK\8:->>'?%6B:1X MCT'4[=[74M&US3K35-,O[>11NAN["]CFM9XB>2DT3J2`<5YE/AV4,JHX+VL5 MB:%2=6C7Y;\DG*ZLK[;=;WL_)?G&`\"93\-L!P77X@A2S[)-7U[PWJ>J:K MJ*P:=801VEK/9-96%C8G]XEQ*^HRY\N#[1NO^"8O[`M]J#ZG/^RO\)S=RRK< M2K'HEQ;V4CEF9BVFVM]!8?/DAE^S^6W`:,J-M?5'PX^$'PN^#VCCP_\`"SX? M^#_A_HJ8;^SO"/A[3=!MY"%"*UPFG00?:90D:)YTYDDV(B[OE%=6&P>>0J47 MBLQP]:A!IRIPHRC.?NJ*;E)66KN][W>G;ZOA[AKQ8CF>%CQ3QKD.89#A'4AC M,#@,GJ4,;F.'G1E1C"IBW"FZ3CS1G.2]HZDE=K5M?P+?LV_%/Q[_`,$U/VT; M#Q+\0O`U[+KOPSU77O"'CSP=.ZV5[>^']8MI]+U&ZT&]O$BLI)&M6AUO0+Z< MK8ZE!':EFBBO3Y7[%_M??\%<[7]MWX)>-?V%-,A\.?#/PW;2Z_XKN[:/0/%7B>(6M]I^F/IM]JVLW6E6\-M=-:06]WJ% M]#%%_0S\9?V3/VW6 M#5(80S.PB2\$09Y&"`NV9_A=^RQ^SO\`!WPUKGA/X7?![P%X(\/^)[6:Q\2: M?HOA^SB_X2"SNH&MIK76[J19+S5+:2WDDA:"]N)XRCD`"N.ADN/PT<3AX8U1 MP-9OEBH)U(NKO'5I)-R4>;72[Y;Z'Q^1^#/'O#V79YPIDW&N783@O.Z^8XFI M[3+JM7.:4,RHJF\/AZO,J="G--0Q$^:I*<6W&,+M'\F?_!OG,D/[;7B=)&1& MN/@7XSCA1B(WE=/$G@R>01ABR91(B60R,P\N5R>3C\ZO^"@()_;C_:R8`D#] MH/XH`L!P&;QEKN`3V+8.`>3@X'%?WO?#G]EK]G3X3>*%\7?#+X*?#7P%XJ2S MN=-7Q!X4\):1HNIBPO!ON[,75G;I/]EN6C5I8#*8V8!B-P!'!>+/V`/V,?'7 MB;6?&7C#]FWX2^(_%?B75KW7M=U_5O".GWFI:MK.IR&:^U+4+F5#+=*\6HVLFKK5VU:/(S'Z/6>5_#[) M>!Z&=9;&OE7$F/SV6-JQQ+HUL-CG%*E"*BZD:M/6_.N5Z:W;MD7_`($U/XH? M\$\X_AUHJB36/&O[)6G>&=(B+",2ZOJOPJM+;3X7D8%8UFNWMX6=N$$A+8"F MOXB/V*?VD]3_`&&/VI-!^+>N^";S7&\(CQ1X5\5^#;F@:-I^@:+8VVFZ/I%A;: M5I6G6D2PV>GZ=86Z6=E96T*8$=M:VT4<,40("QHJ`@`&OE?XI_L*_LA_&KQ/ M/XM^)_[/OPV\6>*)\&\\0WFA):ZSJ!!&&U+4-.DL[C4)`!M\V\>:39A`P48K MLS;*<9CJN!Q.$K4Z5?!1DE[2[BW*5-MWMTM:UG=/I8^Y\1/"G/.+,5P=G/#6 M=X+*>(>#H4O85<;1K5<+5<9824:\/9IR4J%OVV8/AY:Z3K>I6>HZG?#3/@3KGB1M6N&L MHTMK<3?\)8MH+2*2Y:-[%W:XD5J^NO\`@W$('P&_:'R0/^+NZ%U('7P;98/T M/8]^U?LQ;?L:?LL6/P_LOA5!\!/A;_PKG2_$#^++/P9+X1TNXT"+Q,^GOI3: M^;&YBG636WTR5K&7596>^DMOW+3>5^[KTOX8_!/X3?!C3-1TGX2_#OPA\.=+ MUF^CU#5=/\'Z%8Z%9ZC?Q0"WCO+R"PCACGN$@BCA$L@+^4BQ[MJ@"J>58O\` MM*AF>(K4YNG0G2FH1MS2FHIM;62LK:7=^B1>2^&'$6%\1L%XBY[GN`S'%TL@ MHY3CJ&%PU6A*OBH4'0GB:7-:G"G*,J3'N!*@CI?AQ\,O`'PH\/)X/^&GA#P]X%\*V\UQ?6_AWPMI=KHVD07=_,9K MV>*RLXXH4ENI_P![.X7,KYWYR:VAEE2&<5,QYHRI8BE*C*FU[T>?V<[[M-6I MM;==3U,L\.,=E_BQG7B'4Q^&EA,WRV.5PR^,:GUBE)8?!456E4:5-Q<<&Y.* M]Y2J);)L_`?_`(*!>%6\+?M.>*;J-'AB\4Z5X>\76KC"AS=6ATRYN(RN"&.I M:->!V_BDC9LG)KZ/_P""57A42^*OBGXU>+=_9NA:-X8MY6&6$FJ7!_A]'=V7@CPIH/A2TOIQ<7EOH6 MFVVG174ZQ@+-.ELB++*JDHKN"50[1Q7\^Y3X&SRKQ6Q/B#+.<'+*ZF<8W,\+ MD\<-B?;TLQQ]"I2C)U%+V/[JI7=:,UNTE)1;;7Z73P$HXR>*4TU*K*JX6LTG M+FWUON]+(^0?^"C?A;_A(OV;=>U(1>;)X1\0^'M?4%&/#%KYCW7B+7]*T6#:-X675-2A@\PH>`J-.T[ M[<`>5D+DL3_6QKV@:+XHTJ_T'Q#IEEK.C:C$8K_3-1MTNK*\B#I((KFWD!25 M`\:.`PX90>V*\TTS]G[X(Z%J=CK6C_"SP/INK:;/'>:?J%GX>TZ"[L[J)Q)' M/;S)"'BE1T5E="K`@8-:>*'@=B>.^-SN8 M]*MIQ");>Q26)EMHG%O`&CB5(R(8@4R@)GE^&'P]F\)#P#)X.\/-X*@*2Q^% MSIEL=%5X[H7JL+#9Y`(NS]I!"\3?/]XDGS,N\#L^P6<)*&:U^-.%<= MDDL35HU:=:GF&95A#"TI4DJ=&G.35/W4[HPCEV(4\34G6A4J8FB MZ4FX\JBI2C*ZM>]FK6TT:[6/R1_X)3D?\)A\7^?^9<\+?^G+5O\``U^DG[4_ MP6/QT^#'B/P59R0V^O`6^L^&;BX+)!%KNF.9K1)W1'>.&\C,UC-(BGRTN/-* MLL95O2?"'PL^'/P_EO;GP3X+\.^%I]3BAM[^71-,M;![N&)V:*.X:"-#*D32 MR,BMPK.Q'4Y]%.2HP<$[><=B0#QQU!(]NO:OT#@GPW60>'G^H>>UZ&8TJE+, ML/BZE"$HT:U+,*TJ]X*I:<73VO1 M6L^C9_-W^SQ^T7XX_8^\9^*/#'B;PE>W>E:A=0Q>*/"E_NTS6--U&Q\Y(-0T MZ>:)K?SGC;RKCS(Y+&\2%'@N8_W;#[9\3?\`!5+PLNERGPC\+_$4^M&(^1_P MD>HZ78Z7'(1]Z9]-N=3NKB*-F!Q"D4LQ&,0@EA^C7CKX-_##XE[9/'W@?PUX MK>)/+AGUC2K>XOH(P,B.#4`$O(HLEF*)*"7;=NR,'C-#_95_9X\+WD6J:+\( M_!4%[#\T4]SI":E)$XPRO"=3>[2)U(R&5-V<$%=HS^>Y3X9^+7"F'GPUPEXA M9-3XK+^!AYQJTUN]4?(O[67C+4/B%^P5X;\IQ6< M3Q6D>HZC+;75W';1R22O';B5G$*/([+'MR[$;CXQ_P`$I#_Q//C7[Z3X&Q[_ M`.E>*>GK_P#J]:_7CQ#X+\*>+M$_X1SQ/X?TG7-"9K>1M(U*R@N=.,EJ4:V8 MV;IY&8'16B&S$9&4`.",GP?\+?AU\/IKR;P1X,\/>%I=3C@34'T/3+;3FO$M M'F:W2Y:W1&F6%IYFC#$[#+)M^^<_6XKPOS?%^)_"?B!B,WPE59!DM+*\;AY4 MJL:V/Q2PF/PM;%TW%.G2IU/K_M53;%G+%4,2IQ;I0]GRM-<[N MVY7UM=R6FNVY^:W_``54(/@WX/8(X\1^)L^V=+TTC/U!!'LI/Y=KXK\;>(]'>;;O-O)<>"_"*VUPB9&YK6Y$-PJ@@EH^",DC]./% M_P`.?`OQ`MK*W\;>%-"\4V^GS//8P:WIUOJ$=I/+$L&-;T&V\3):1>)M6UQ[$7`L8+F&ZETO3$TR M^OX'^U3P1PW=U<2PE[)I8ULD#LX_9KQQ\,?`'Q'LQ8^._"/A[Q5:Q;?)36=+ MMKUX&9B=UO-,KRVY!9B#`\9W'."A6,;&`*@$"OA*'@MX@9%A<\X6X0XXRO`\(Y[6Q-> MK@<;@,3+&86EC%&GB*%"K3YX0]IA_P!U>$DK)2=G='.L%BHJIAZ6)C##U9MI M\EZE-2MSV5[-MWL[Q[NQ\"_\$U_@%K^A7.M?&_Q3IMUIL6K:7_8/@NVOH9(; MNZL;N9+[5M=$,T,;I93I':66G2$*9U>_EV^6+=W^"_VM/`VO?"O]HOQV]Q%- M9QZOXIO/'?AC5%4".YT_6=1GU6UGMI)-J--IUYNM[E&D0K<6A,;*;:V M=I;5=7L8KI[21L;WLYG'GVC2%4,AMY(]Y0;N@Q[N>^`."QGAYD'!O#^/A@L= MPWCZF983-,13G*G7QF)O]<]M",O:1C52IPA)*I*,*,;Q;=EO5P%\)&C1:4J4 ME*,FK-R6LF]=%)]+NWGN_P`>]:_;Z^*/QM\&1_!GPC\-H(/'OCG3_P#A&+_5 M].U22[#07,)M]6N=.TZ6T0V;R%=OES]C*&>R_:J M^%$-RH6>U\2:K!,`P91-#X>\0Q3`.>"K3+)M8;58%"H"L%7^@/X?_`GX2?#" M>]N/`7@+PYX:N[Q?L]S?65@K:A)"8TS#]NN7FNA`VP%H/-,1;D*.09])^!'P M=T'6X/$NA_#7P9I/B"UNI;VVUFQ\/Z?;ZC;W4PE6:>&Z2$2I-*L\JO)N)(D; MCDY\>OX*<=YCFW"7$W%?'>&S',^'>N_\`!2C4 M/`?Q+^(7@KQ;\.[?7-)\+^-?$WA_2=4\.ZH=-U!].TG5KFSM&O;/4TN8;B=K M>)&DN;:XMXI=RLD*`YKX=_:T_:MO#BW]K:37D\&I: MYJMSJ\]G_H[_`&"+FVMY;6/[';6T\LXN)YG=`K[:_>'Q;^SG\#?'MX^H^+OA M?X0UK4I79YM1GTFW@OYY&!S)/>68M[B64X^:1Y2[$EF);!">"_V=?@A\/M13 M5/!_PR\)Z+JB-OBU.+35NM1@*D%?L][?/*X3S7,'B5">38AYK1P\<2J]"E2J-QA&5%-02]I&,W%EG>^FUK'PWX4_9)\2^(?V%X/AGK4`T[X@W.H MWGQ(T&PO6\N32=6O+IKFRT2^8*3:W%WI$K:9?*FY;:[O9079(2:^$OV;OVEO M&O[(/BGQ3X2\3^$+W4-(O[Z(>(_"MY*^DZSI&KV7F6WVNP-Q&\#S30*T4T:\J\)WA0QPSZII=M+=PH&.$BO$2.ZC0;B1&DRHK$L%!))]SB'P5Q%&KPIG/`&= MKA_B+A/*,+D5'$8NG/$8?-,LPJM"ACHQES-)RJ6OSJ,9*"NHHTG@9)TI8>I[ M*5**BVU>Z5DKV7WZ,_.'Q-_P56\-1Z9(/!WPPUZ?69(V2%O$FIZ9I^F03Y&' ME73KC4;N:"/DNA^QRLRB,F,-Y@_2SX/^,+WQ_P#"[X>^--36"+4O%7@OPSX@ MU"&V4I;PWVKZ3;7MW%"A:1DBCN)I(T1I'9%0*S%@2>"T#]EK]GWPQ=Q7^B_" M?P=:WD+B2*>;2UOVC90`K1C49+L(R8!0C&U@&'(%>^6L$5NBQ0QI%$D:(D:+ ML1$C&U%55PH"KA5`4850/N@`?<<$Y-XB8#&8_&\=<1Y9G/MZ-.C@\'E&"EA, M-A'"2E*K*51QE.4XZ.*@U&ZM.5M=L-3QD?:?6*T*B4WRI1LU&]DD_P#/[M$? "_]D_ ` end